Somatic hematopoietic TP53 mosaicism in women with breast cancer exposed to ionizing radiation

被引：0
|
作者：
Melnov, Sergey [1 ]
Murphy, Patricia [2 ]
Foley, Thomas [3 ,4 ]
Nadyrov, Eldar [5 ]
Kipen, Vyacheslav [1 ]
Leushev, Boris [1 ]
Modugno, Francesmary [6 ]
机构：
[1] Int Sakharov Environm Univ, Belorussian Sci Ctr Ecol, Minsk, BELARUS
[2] GeneWISE, Bar Harbor, ME USA
[3] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Dept Endocrinol, Pittsburgh, PA USA
[5] Gomel State Med Univ, Dept Pathol, Gomel, BELARUS
[6] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA
来源：
BREAST JOURNAL | 2018年 / 24卷 / 05期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1111/tbj.13056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：852 / 854
页数：3
相关论文
共 50 条
  • [31] Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer
    Sheng, Shuyan
    Xu, Ye
    Guo, Yonghai
    Yao, Lu
    Hu, Li
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (02) : 487 - 495
  • [32] Germline TP53 mutations in women with very early onset breast cancer (BR).
    Masciari, S
    Harris, L
    Branda, K
    Petkovska, A
    Paez, J
    Haber, D
    Digianni, L
    Sellers, W
    Li, F
    Garber, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 109S - 109S
  • [33] TP53 somatic mutations and LOH profile in colorectal cancer in Romania
    Murarasu, Daniela
    Puiu, Liliana
    Pitica, Ioana Madalina Aldea
    Mambet, Cristina
    Mihalcea, Corina Elena
    Marincas, Augustin Marian
    Cinca, Sabin
    Brasoveanu, Lorelei
    Diaconu, Carmen Cristina
    ROMANIAN BIOTECHNOLOGICAL LETTERS, 2018, 23 (02): : 13530 - 13540
  • [34] Somatic TP53 mutations alter the immune micro-environment after chemotherapy in breast cancer
    Nixon, Mellissa
    Estrada, M. Valeria
    Opalenik, Susan
    Hicks, Donna
    Korrer, Michael
    Pilkinton, Mark
    Sanders, Melinda
    Salgado, Roberto
    Mallal, Simon
    Kim, Young
    Cook, Rebecca
    Arteaga, Carlos
    Balko, Justin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [35] The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
    Olivier, M
    Langerod, A
    Carrieri, P
    Bergh, J
    Klaar, S
    Eyfjord, J
    Theillet, C
    Rodriguez, C
    Lidereau, R
    Bièche, I
    Varley, J
    Bignon, Y
    Uhrhammer, N
    Winqvist, R
    Jukkola-Vuorinen, A
    Niederacher, D
    Kato, S
    Ishioka, C
    Hainaut, P
    Borresen-Dale, AL
    CLINICAL CANCER RESEARCH, 2006, 12 (04) : 1157 - 1167
  • [36] Ionizing Radiation-Induced Responses in Human Cells with Differing TP53 Status
    Mirzayans, Razmik
    Andrais, Bonnie
    Scott, April
    Wang, Ying W.
    Murray, David
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (11): : 22409 - 22435
  • [37] Radiation-Associated Secondary Cancer in Patients With Breast Cancer Harboring TP53 Germline Variants
    Cederquist, Gustav Y.
    Boe, Lillian A.
    Walsh, Michael
    Freedman, Gary M.
    Maxwell, Kara N.
    Taunk, Neil
    Braunstein, Lior Z.
    JAMA ONCOLOGY, 2024, 10 (11) : 1588 - 1590
  • [38] Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
    Barekati, Zeinab
    Radpour, Ramin
    Kohler, Corina
    Zhang, Bei
    Toniolo, Paolo
    Lenner, Per
    Lv, Qing
    Zheng, Hong
    Zhong, Xiao Yan
    HUMAN MOLECULAR GENETICS, 2010, 19 (15) : 2936 - 2946
  • [39] TP53 and ovarian cancer
    Schuijer, M
    Berns, EMJJ
    HUMAN MUTATION, 2003, 21 (03) : 285 - 291
  • [40] Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer
    Foedermayr, Mathilde
    Sebesta, Miriam
    Rudas, Margaretha
    Berghoff, Anna S.
    Promberger, Regina
    Preusser, Matthias
    Dubsky, Peter
    Gnant, Michael
    Steger, Guenther G.
    Weltermann, Ansgar
    Zielinski, Christoph C.
    Zach, Otto
    Bartsch, Rupert
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2016, 9 (02) : 70 - 75
12345